Published: December 3rd 2024 | Updated: December 6th 2024
ASH 2024 Preview for Community Oncologists: The Show and After Show
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: December 11th 2024 | Updated: December 14th 2024
Biomarkers and Treatment Strategies in CAR T-Cell Therapy for R/R Multiple Myeloma
Published: December 12th 2022 | Updated: December 14th 2024
When to Stop or Switch JAK Inhibitor Therapy in Myelofibrosis
Published: January 6th 2023 | Updated: December 14th 2024
Bridging Options for CAR T-Cell Therapy in R/R DLBCL
Published: August 29th 2022 | Updated: December 14th 2024
POLL: What Frontline Treatment Would You Choose for Favorable- and Intermediate-Risk RCC?